Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 Central and Eastern European countries

被引:30
作者
Nagai, K
Appelbaum, PC [1 ]
Davies, TA
Kelly, LM
Hoellman, DB
Tambic Andrasevic, A
Drukalska, L
Hryniewicz, W
Jacobs, MR
Kolman, J
Miciuleviciene, J
Pana, M
Setchanova, L
Thege, MK
Hupkova, H
Trupl, J
Urbaskova, P
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, 500 Univ Dr, Hershey, PA 17033 USA
[2] Sera & Vaccine Lab, Warsaw, Poland
[3] Med Acad Latvia, Childrens Hosp, Riga, Latvia
[4] Univ Zagreb, Hosp Infect Dis, Zagreb 41000, Croatia
[5] Case Western Reserve Univ, Cleveland, OH 44106 USA
[6] Univ Ljubljana, Ljubljana, Slovenia
[7] Kaunas Med Univ Hosp, Kaunas, Lithuania
[8] Inst Cantacuzino, Bucharest, Romania
[9] Acad Med Sofia, Hosp Infect Dis, Sofia, Bulgaria
[10] Natl Ctr Epidemiol, Budapest, Hungary
[11] St Cyril & Method Hosp, Bratislava, Slovakia
[12] Natl Canc Inst, Bratislava, Slovakia
[13] Natl Antibiot Reference Lab, Prague, Czech Republic
关键词
D O I
10.1128/AAC.46.2.546-549.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Among 1,011 recently isolated Streptococcus pyogenes isolates from 10 Central and Eastern European centers, the MICs at which 50% of isolates are inhibited (MIC(50)s) and the MIC(90)s were as follows: for telithromycin, 0.03 and 0.06 mug/ml, respectively; for erythromycin, azithromycin, and clarithromyrin, 0.06 to 0.125 and 1 to 8 mug/ml, respectively; and for clindamycin, 0.125 and 0.125 mug/ml, respectively. Erythromycin resistance occurred in 12 3 % of strains. Erm(A) [subclass erm(TR)] was most commonly encountered (60.5%), followed by mef(A) (23.4%) and erm(B) (14.5%). At <0.5 mug/ml, telithromycin was active against 98.5% of the strains tested.
引用
收藏
页码:546 / 549
页数:4
相关论文
共 25 条
[1]   High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes:: results of a Spanish multicentre study in 1998 [J].
Alós, JI ;
Aracil, B ;
Oteo, J ;
Torres, C ;
Gómez-Garcés, JL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) :605-609
[2]   Carriage of antibiotic-resistant Streptococcus pneumoniae by children in Eastern and Central Europe - A multicenter study with use of standardized methods [J].
Appelbaum, PC ;
Gladkova, C ;
Hryniewicz, W ;
Kojouharov, B ;
Kotulova, D ;
Mihalcu, F ;
Schindler, J ;
Setchanova, L ;
Semina, N ;
Trupl, J ;
Tyski, S ;
Urbaskova, P ;
Jacobs, MR .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :712-717
[3]   Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in France [J].
Arpin, C ;
Canron, MH ;
Noury, P ;
Quentin, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :133-134
[4]   DETECTION OF ERYTHROMYCIN RESISTANCE BY THE POLYMERASE CHAIN-REACTION USING PRIMERS IN CONSERVED REGIONS OF ERM RIBOSOMAL-RNA METHYLASE GENES [J].
ARTHUR, M ;
MOLINAS, C ;
MABILAT, C ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :2024-2026
[5]   In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes:: Influences of resistance mechanisms and methodological factors [J].
Bemer-Melchior, P ;
Juvin, ME ;
Tassin, S ;
Bryskier, A ;
Schito, GC ;
Drugeon, HB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :2999-3002
[6]   Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients [J].
Bingen, E ;
Fitoussi, F ;
Doit, C ;
Cohen, R ;
Tanna, A ;
George, R ;
Loukil, C ;
Brahimi, N ;
Le Thomas, I ;
Deforche, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1453-1457
[7]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[8]  
Cornwell TB, 1998, J ADVERTISING, V27, P1
[9]   Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies [J].
Davies, TA ;
Kelly, LM ;
Jacobs, MR ;
Appelbaum, PC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) :1444-1448
[10]   Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada [J].
De Azavedo, JCS ;
Yeung, RH ;
Bast, DJ ;
Duncan, CL ;
Borgia, SB ;
Low, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2144-2147